Tevogen, Inc. (TVGN)
7.30
-0.06
(-0.82%)
USD |
NASDAQ |
Sep 14, 10:13
Tevogen Total Assets (Quarterly) : 4.728M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.728M |
| March 31, 2026 | 4.921M |
| December 31, 2025 | 4.383M |
| September 30, 2025 | 4.494M |
| June 30, 2025 | 4.269M |
| March 31, 2025 | 4.073M |
| December 31, 2024 | 3.462M |
| September 30, 2024 | 4.290M |
| June 30, 2024 | 3.310M |
| March 31, 2024 | 3.363M |
| December 31, 2023 | 5.506M |
| Date | Value |
|---|---|
| September 30, 2023 | 26.41M |
| June 30, 2023 | 26.38M |
| March 31, 2023 | 25.47M |
| December 31, 2022 | 357.14M |
| September 30, 2022 | 354.54M |
| June 30, 2022 | 352.98M |
| March 31, 2022 | 352.83M |
| December 31, 2021 | 352.85M |
| September 30, 2021 | 0.1668M |
| June 30, 2021 | 0.1469M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 13.62M |
| Shareholders Equity (Quarterly) | -8.889M |
| Debt to Equity Ratio | -1.062 |
| Current Ratio | 0.3267 |
| Net Debt Paydown Yield | -3.84% |